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of osseous involvement in Sarcoidosis has been increasing 
due to improved imaging techniques such as MRI and PET, 
true incidence rate have been difficult to assess for seve-
ral reasons. First is the asymptomatic nature of osseous 
involvement. Secondly, because when symptoms of bone 
pain do exist, their diagnosis is obscured by classic mus-
culoskeletal clinical manifestations of Sarcoidosis including 
arthralgias, sarcoid arthritis and sarcoid myopathies. Thir-
dly, as seen in the case to be described below, because 
skeletal involvement in Sarcoidosis can be misinterpreted 
as metastatic involvement of the bones. Radiographically 
reported incidence of skeletal involvement in the setting of 
Sarcoidosis occurs in only 5% of patients. 7
The Case.
A 33-year-old Caucasian male, with past medical history sig-
nificant for mediastinal Germ Cell Tumor (GCT), presented 
to the emergency department (ED) with 2-month history of 
worsening exertional dyspnea. When diagnosed with GCT 3 
years ago, CAT scan imaging of his chest showed patholo-
gically enlarged lymph nodes extending from the anterior 
mediastinum into the middle mediastinum measuring 8.1 
x 10.0 cm on the right and 8.0 x 9.6 cm on the left. Subse-
quent lymph node biopsy revealed immature GCT consis-
ting predominantly of yolk sac tumor with teratomatous 
component. Testicular ultrasound was unremarkable at that 
time. 
The patient’s dyspnea significantly worsened over the week 
prior. He reported a productive cough with clear sputum 
and denied palpitations or chest pain. On physical exam 
Introduction.
Sarcoidosis is a chronic inflammatory disease, characterized 
by noncaseating granulomas, which can affect any organ, 
but most commonly the lungs. The diagnosis of sarcoidosis 
is one of exclusion after ruling out pathologies such as my-
cobacterial, fungal infections, malignancy etc. The etiology 
of Sarcoidosis is unknown but is theorized to be an infec-
tious or noninfectious environmental agent that triggers an 
inflammatory response in a genetically susceptible host. 
Clinical features include nonproductive cough and short-
ness of breath on exertion. Hallmark findings include bila-
teral hilar adenopathy on chest x-ray and elevated serum 
Angiotensin-converting enzyme and calcium. Systemic fin-
dings include erythema nodosum, uveitis, arthralgias and 
arthritis. Sarcoidosis is typically managed with systemic 
corticosteroids.1
Cases of Sarcoidosis are annually documented worldwide at 
varying incidence rates. Diagnosis most often occurs under 
the age of 50-years-old, peaking in the 3rd and 4th decades 
of life2 with the highest incidence (5-40 cases per 100,000) 
reported in Northern European nations, particularly Ireland 
and Scandinavia.3 In the United Sates, African Americans 
are approximately three times more likely to be affected by 
sarcoidosis compared to Caucasians (35.5 cases per 100,000 
versus to 10.9 cases per 100,000 respectively).4  Despite 
geographic and racial differences, sarcoidosis uniformly 
shows a greater preponderance towards females. 5
It is well documented that over 90% of cases of Sarcoido-
sis have pulmonary, cutaneous or ocular involvement with 
little of no skeletal involvement.6 Even though detection 
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Abstract.
Sarcoidosis is a systemic granulomatous disease of unknown etiology that typically affects young adults. Diagnostic criteria for sarcoidosis 
include involvement of two or more of the following organ systems: 1) pulmonary infiltrates; 2) bilateral hilar adenopathy; and 3) skin 
and/or eye lesions. Musculoskeletal system is less commonly involved. For that reason potential presenting symptoms can vary and 
make the diagnosis very challenging; particularly if a patient has symptoms that mimic other conditions. Musculoskeletal involvement for 
example can mimic malignancy. The following case describes a patient with known history of primary metastatic mediastinal Germ Cell 
Tumor (GCT) with teratomatous elements who is diagnosed with sarcoidosis involving skeletal tissues. 
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he was afebrile, tachycardic, and tachypneic and found to 
be in moderate respiratory distress. Bibasilar crepitus was 
noted and arterial blood gas revealed a PaO2 of 57.3 mmHg 
on room air, indicating hypoxemia. A follow up CAT scan 
revealed a 14.4 x 11.3 cm anterior mediastinal mass with 
diffuse reticulonodular infiltrates in both lungs. Subsequent 
left lung video-assisted thoracoscopy and biopsy found 
predominantly well-defined large multinucleated giant cell 
granulomas consistent with Sarcoidosis. The patient was 
started on oral steroid therapy without improvement in his 
symptoms. 
Over the ensuing 6 months the disease progressed and he 
presented to the ED once again with superior vena cava 
syndrome. Soon after, due to compression, the patient de-
veloped a pericardial effusion with signs of heart failure 
and underwent mediastinal debulking. Surgical pathology 
revealed a 12.5cm mature teratoma with extensive necrosis. 
He reported chronic fatigue, exertional dyspnea, and a ra-
cing heart without fever or chest pain and was placed on 
home oxygen and BiPAP due to chronic hypoxemia. A PET/
CT was performed to evaluate suspicions of GCT dissemina-
tion. Results showed abnormal hypermetabolic foci in the 
mediastinal lymph nodes, left hilum and subcarinal lym-
ph nodes, periportal, peripancreatic and aortocaval lymph 
nodes. Hypermetabolic foci were also noted in multiple 
osseous lesions including the proximal femoral shaft, left 
trochanteric region, lumbar vertebra, and right third lateral 
rib. Subsequent left iliac bone core biopsy and FNA revealed 
bone marrow with numerous epithelioid granulomas in a 
background of normocellular bone marrow consistent with 
sarcoidosis. The patient never complained of bone pain. 
Discussion.
The described patient was found to have multiple painless 
bone lesions on imaging studies related to his GCT. Given 
the extensive and well-documented history of GCT, the lea-
ding diagnosis after the PET/CT revealed the skeletal lesions 
was first thought to be metastatic disease. However it is 
important to keep in mind that at the time the patient al-
ready had an established diagnosis of Sarcoidosis. Other di-
fferential diagnosis for multiple skeletal lesions can include 
multiple myeloma, brown tumors of hyperparathyroidism, 
lymphoma, histiocytosis, osteomyelitis, Paget’s disease, 
and fibrous dysplasia. 
The incidence of Sarcoidosis with skeletal involvement has 
been speculated to range from 3% to 38%.5-7 However, skele-
tal Sarcoidosis may or may not cause significant musculos-
keletal manifestations. Therefore, since most patients are 
asymptomatic and radiologic examination is not routinely 
performed, sarcoid bone lesions could go undetected and 
true incidence of skeletal Sarcoidosis could be underesti-
mated. If it was not for our patient’s GCT, he likely would 
not have required imaging studies. 
Skeletal involvement has been documented more frequently 
in the phalanges as compared to the long bones, vertebra, 
skull and pelvic bones.11 Our patient had no involvement of 
the bones of his hands or feet but rather involved his long 
bones, pelvic bones, vertebra and ribs. Pure skeletal invol-
vement is rare in the setting of Sarcoidosis. The presence 
of skeletal sarcoidosis does not seem to have an impact 
Figure 1. Abnormal hypermetabolism of the left trochanteric region. These PET/CT images were interpreted 
by evaluation of both the anatomic (CT) and metabolic (PET) data which were electronically fused.
Figure 2. Abnormal hypermetabolism corresponding to L3 vertebra.
Figure 3. Mild abnormal hypermetabolism in fusiform fashion of the right third lateral rib. Additional non-
osseous regions of hypermetabolism are seen corresponding to pathologically enlarged mediastinal and 
hilar lymph nodes. .
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on the degree of respiratory dysfunction.8  However, it is 
difficult to assess to what degree Sarcoidosis contributed to 
his pulmonary symptoms as he had an extensive primary 
tumor located in his mediastinum. 
Since our patient was being followed and treated for his 
GCT, we had the luxury of knowing that previous imaging 
studies did not show any skeletal involvement. It is quite 
certain that pulmonary sarcoidosis involvement preceded 
the skeletal involvement in this case. As stated above, 
since radiologic studies would not routinely be preformed, 
normally it would be extremely hard to determine whether 
skeletal sarcoidosis preceded pulmonary and mediastinal 
involvement or if sarcoidosis first presented with pulmo-
nary and mediastinal manifestations. 
Regarding laboratory testing, elevated inflammatory mar-
kers and ACE levels are more frequently found in sarcoido-
sis with skeletal involvement.9 However our patient had 
both pulmonary and skeletal involvement as well as a 
cancer, which could all contribute and affect inflammatory 
markers and alter lab data.
First line therapy for sarcoidosis has traditionally been 
systemic corticosteroids while refractory cases have often 
been managed with Methotrexate.10 The combination of 
history of GCT with prior surgery and chemotherapy, along 
with a wide spread dissemination of sarcoidosis in our 
patient, creates a challenge to the more traditional sar-
coidosis treatment methods particularly because there is 
increased likelihood of infection due to impaired immunity. 
In this case, the imaging features that were unexpectedly 
found to be sarcoid rather than metastasis would likely 
be considered as nonspecific and yield a broad differen-
tial diagnosis in many scenarios. Previous data suggests 
that, although rare, osseous involvement in sarcoidosis can 
be differentiated from a destructive lytic bone lesion by 
the absence of periostitis on conventional radiography.15 
However, definitive diagnosis can only be made with biop-
sy, which is necessary to rule out metastatic disease. In 
the future, appropriate use of PET scan may help in timely 
detection of osseous involvement in patients with sarcoido-
sis.16
